Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Expensive Performer
162.4200 1.36 (0.84%)
NSE Feb 26, 2026 15:31 PM
Volume: 3.3M
 

162.42
0.84%
ICICI Direct
PPL owns 17 development and manufacturing facilities across India, US and UK with capabilities in sterile, API, formulations, drug discovery and manufacturing of nutrition products. The company holds 49% stake in AbbVie Therapeutics, JV with...
Number of FII/FPI investors decreased from 250 to 244 in Dec 2025 qtr
More from Piramal Pharma Ltd.
Recommended